Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN783405 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Epithelial Splicing Regulatory Protein 1 (ESRP1) (N-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- 12 amino acid peptide near the amino terminus of Human RBM35A
- Description
- Affinity Chromatography purified via peptide column
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- N-Term
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition.
Flows and flaws in primary central nervous system lymphoma.
The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.
RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer.
Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, Guo W, Xing Y, Carstens RP
The EMBO journal 2010 Oct 6;29(19):3286-300
The EMBO journal 2010 Oct 6;29(19):3286-300
Flows and flaws in primary central nervous system lymphoma.
Ferreri AJ, Illerhaus G, Zucca E, Cavalli F, International Extranodal Lymphoma Study Group
Nature reviews. Clinical oncology 2010 Aug;7(8):doi:10.1038/nrclinonc.2010.9-c1; author reply doi:10:1038/nrclinonc.2010.9-c2
Nature reviews. Clinical oncology 2010 Aug;7(8):doi:10.1038/nrclinonc.2010.9-c1; author reply doi:10:1038/nrclinonc.2010.9-c2
The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.
Warzecha CC, Shen S, Xing Y, Carstens RP
RNA biology 2009 Nov-Dec;6(5):546-62
RNA biology 2009 Nov-Dec;6(5):546-62
RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer.
Leontieva OV, Ionov Y
Cell cycle (Georgetown, Tex.) 2009 Feb 1;8(3):490-7
Cell cycle (Georgetown, Tex.) 2009 Feb 1;8(3):490-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of RBM35A in rat colon tissue lysate with RBM35A antibody at 0.5 ?g/ml in (A) the absence and (B) the presence of blocking peptide.
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Immunohistochemistry of RBM35A in Human colon tissue with RBM35A antibody at 2.5 ?g/ml.
